US11001594B2

Heterocyclic modulators of HIF activity for treatment of disease

University of Texas System

Abstract

The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Philip Jones
Priority date: August 24, 2012
Filing date: December 21, 2018
Grant date: May 11, 2021
Publication date: May 11, 2021
Language: en
PDF source: https://patentimages.storage.googleapis.com/54/a9/e7/71215c4450e37a/US11001594.pdf
Metadata fetched: August 29, 2026 00:27